Recruiting Studies
Advanced SearchData: ClinicalTrials.gov · Source of record for eligibility and locations
Top Cities for Pneumonia Clinical Trials
Pneumonia clinical trials are recruiting across 95 cities. Here are the cities with the most active studies:
Pneumonia Trial Phases
28 research organizations are sponsoring pneumonia trials.
About Pneumonia
Pneumonia is an infection that inflames the air sacs in one or both lungs, which may fill with fluid or pus. It can range from mild to life-threatening. Treatment depends on the cause and severity, including antibiotics, antivirals, and supportive care.
Clinical trials are advancing new treatments for pneumonia. Currently, 29 studies are recruiting a combined 82,944 participants across the United States. Research is being conducted by 28 organizations including University of California, San Diego, UMC Utrecht, Pfizer and 25 others.
2026 Pneumonia Research Landscape
As of July 2026, the pneumonia clinical trial landscape includes 29 actively recruiting studies across 95 cities in the United States. These studies are collectively seeking 82,944 participants, with an average enrollment target of 2,860 per study.
The research spans multiple phases of development: 10 studies are in NA, 5 studies are in PHASE2, 4 studies are in PHASE3, 2 studies are in PHASE4, 1 study is in EARLY_PHASE1. The presence of Phase 3 trials indicates that some pneumonia treatments are in late-stage testing and may be approaching regulatory review.
Research is being led by 28 different organizations, including University of California, San Diego, UMC Utrecht, Pfizer, Intermountain Health Care, Inc., University of Manitoba, and 23 others. The large number of sponsors reflects significant research interest and investment in pneumonia treatment advancement.
Geographically, pneumonia trials are most concentrated in Chicago, Illinois (4 trials); New York, New York (3 trials); Columbus, Ohio (3 trials); Sacramento, California (3 trials); St Louis, Missouri (3 trials) and 7 other cities.
Featured Pneumonia Studies
Highlighted recruiting studies for pneumonia, selected by enrollment size and research scope.
Preparedness Through Respiratory Virus Epidemiology and Community Engagement
The CHARM network will be established through three primary institutions-Beth Israel Deaconess Medical Center (BIDMC), the University of California San Diego (UCSD), and the University of Washington (UW)-along with their subcontracting institutions. At UCSD and partner sites, the CHARM network will be implemented via the PREVENT project. All PREVENT participants will be consented in to Component A...
Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia
REMAP-CAP is a randomised, embedded, multifactorial, adaptive platform trial for community-acquired pneumonia. The purpose of this study is to evaluate the effect of a range of interventions to improve outcome of patients admitted to intensive care with community-acquired pneumonia. In addition, REMAP-CAP provides and adaptive research platform for evaluation of multiple treatment modalities in ...
A Study to Learn About How 20-Valent Pneumococcal Conjugate Vaccine Works in a Real-world Setting
The purpose of this study is to learn about how well the 20-valent pneumococcal conjugate vaccine (20vPnC) works against radiologically-confirmed community-acquired pneumonia (RAD+CAP) due to the 7 new serotypes (types of a bacteria called Streptococcus pneumoniae that cause pneumonia) included in 20vPnC vaccine. This study is seeking participants who: * are male or female ≥65 years of age. * ar...
Frequently Asked Questions About Pneumonia Clinical Trials
Are there pneumonia clinical trials near me?
Yes, there are 29 pneumonia clinical trials currently recruiting across 95+ cities in the United States, including Chicago, Illinois; New York, New York; Columbus, Ohio. Browse the studies above to find one at a location convenient for you.
How do I join a pneumonia clinical trial?
To join a pneumonia clinical trial: 1) Browse the available studies on this page, 2) Click on a study that interests you, 3) Check the study locations to find a site near you, 4) Review the eligibility criteria, and 5) Contact the study site or complete the eligibility form. The process is free and you can withdraw at any time.
Are pneumonia clinical trials free?
Yes, participation in pneumonia clinical trials is free. Study-related treatments, medical tests, and doctor visits are provided at no cost to participants. Many studies also offer compensation for your time and travel expenses.
What types of pneumonia treatments are being studied?
Current pneumonia clinical trials are testing a range of approaches across NA (10 studies), PHASE2 (5 studies), PHASE3 (4 studies), PHASE4 (2 studies), EARLY_PHASE1 (1 study). These include new drugs, combination therapies, medical devices, and other interventions sponsored by 28 research organizations.
Is it safe to participate in pneumonia clinical trials?
Clinical trials are carefully regulated by the FDA and institutional review boards (IRBs). All trials must follow strict safety protocols, and participants receive close medical monitoring throughout the study. You can withdraw from a trial at any time without penalty.
Data updated July 16, 2026 from ClinicalTrials.gov
About This Data
Data: ClinicalTrials.gov · Source of record for eligibility and locations
Clinical trial information on this page is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health (NIH) and National Library of Medicine (NLM). Study data is refreshed every hour to ensure accuracy.
Medical Disclaimer: The information provided on this page is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before making decisions about clinical trial participation or changes to your treatment plan.
Page reviewed by the HelloStudys Research Team · Last updated July 16, 2026 · Data from ClinicalTrials.gov